Literature DB >> 6291622

Prostacyclin prolongs viability of washed human platelets.

G J Blackwell, M Radomski, J R Vargas, S Moncada.   

Abstract

The functional viability of stored human platelets, washed in the presence and absence of prostacyclin, was examined over a 96 h period. Platelet counts, aggregation responses and cyclic AMP levels were monitored as well as the spontaneous generation of thromboxane B2 and the liberation of labelled oleate from cellular phosphatides. In suspensions prepared without prostacyclin in the medium, platelet counts declined rapidly as did the sensitivity to aggregating agents. In addition, substantial amounts of thromboxane B2 were generated during preparation and storage and oleate liberation occurred at a rapid rate. In contrast, in prostacyclin-washed platelets, aggregation was maintained throughout the study period and there was little generation of thromboxane B2. Moreover, only a gradual decrease in platelet count and a slow increase in the rate of oleate liberation was observed when compared with controls. However, cyclic AMP levels rapidly declined when platelets were resuspended in prostacyclin-free medium.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6291622     DOI: 10.1016/0304-4165(82)90009-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids.

Authors:  R M Palmer; L Bridge; N A Foxwell; S Moncada
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

2.  Protective effect of beraprost sodium, a new chemically stable prostacyclin analogue, against the deterioration of baroreceptor reflex following transient global cerebral ischaemia in dogs.

Authors:  J Kurihara; T Sahara; H Kato
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

3.  Endothelium-derived relaxing factor inhibits in vitro platelet aggregation.

Authors:  B Furlong; A H Henderson; M J Lewis; J A Smith
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

Review 4.  Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

5.  Selective inhibition of protein kinase C. Effect on platelet-activating-factor-induced platelet functional responses.

Authors:  C T Murphy; J Westwick
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

6.  Platelet-reactive sites in collagens type I and type III. Evidence for separate adhesion and aggregatory sites.

Authors:  L F Morton; A R Peachey; M J Barnes
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

7.  The relationship between cytosolic Ca2+, sn-1,2-diacylglycerol and inositol 1,4,5-trisphosphate elevation in platelet-activating-factor-stimulated rabbit platelets. Influence of protein kinase C on production of signal molecules.

Authors:  C T Murphy; M Elmore; S Kellie; J Westwick
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

8.  Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue.

Authors:  M Elias; A Heethuis; M Weggemans; V Bom; N Blom; R L McShine; M R Halie; C T Smit Sibinga
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

9.  Role of type 1 and type 2A phosphatases in signal transduction of platelet-activating-factor-stimulated rabbit platelets.

Authors:  C T Murphy; J Westwick
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

10.  A role for protein phosphorylation in modulating Ca2+ elevation in rabbit platelets treated with thapsigargin.

Authors:  C T Murphy; A J Bullock; J Westwick
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.